Aegis Capital Upgrades SciClone Pharmaceuticals (SCLN) to Buy

July 16, 2013 8:40 AM EDT Send to a Friend
Get Alerts SCLN Hot Sheet
Price: $8.49 -0.47%

Rating Summary:
    2 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 3 | Down: 17 | New: 2
Trade SCLN Now!
Join SI Premium – FREE
Aegis Capital upgraded SciClone Pharmaceuticals (NASDAQ: SCLN) from Hold to Buy.

For an analyst ratings summary and ratings history on SciClone Pharmaceuticals click here. For more ratings news on SciClone Pharmaceuticals click here.

Shares of SciClone Pharmaceuticals closed at $5.67 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Add Your Comment